Provided by Tiger Fintech (Singapore) Pte. Ltd.

Opthea Ltd

3.41
+0.0000
Volume:- -
Turnover:- -
Market Cap:524.84M
PE:-1.62
High:3.41
Open:3.41
Low:3.41
Close:3.41
Loading ...

Why this sold-off ASX All Ords dividend stock is 'well placed to generate long-term shareholder value'

MotleyFool
·
28 Mar

Closing Bell: Tech tumble and Trump tariffs trample Thursday

Stockheads
·
27 Mar

Pengana freezes fund redemptions as it braces for big Opthea loss

The Australian Financial Review
·
27 Mar

Analysts Offer Insights on Healthcare Companies: Opthea Limited (OtherCKDXF), Outset Medical (OM) and Maravai Lifesciences Holdings (MRVI)

TIPRANKS
·
26 Mar

HM1 Says Revaluation of Opthea's Holding Value to Negatively Impact NAV by 1.6%

MT Newswires Live
·
26 Mar

Opthea downgraded to Market Perform from Outperform at Leerink

TIPRANKS
·
26 Mar

Opthea cut to Market Perform at Leerink on failed sozinibercept trial

TIPRANKS
·
26 Mar

Opthea double downgraded to Underperform from Buy at Jefferies

TIPRANKS
·
26 Mar

Opthea downgraded to Neutral from Buy at H.C. Wainwright

TIPRANKS
·
26 Mar

Trading in Opthea Still Halted After Phase 3 Study Failure

Dow Jones
·
26 Mar

Opthea Cut to Market Perform From Outperform by Leerink Partners

Dow Jones
·
25 Mar

Opthea Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
25 Mar

Opthea Ltd : H.c. Wainwright Cuts Target Price to $2 From $12

THOMSON REUTERS
·
25 Mar

Ocean Power Technologies Enters New Market with WAM-V® Sale for a Mining Deployment in Latin America

GlobeNewswire
·
25 Mar

Jefferies & Co Downgrades Opthea to Underperform From Buy, Adjusts Price Target to $1 From $8

MT Newswires Live
·
25 Mar

Opthea Limited: Hold Rating Amid Phase 3 Trial Failure and Financial Uncertainty

TIPRANKS
·
25 Mar

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Opthea Limited Sponsored ADR (OPT) and Larimar Therapeutics (LRMR)

TIPRANKS
·
25 Mar

Regal’s listed funds slash value of biotech Opthea by two-thirds

The Australian Financial Review
·
25 Mar

Opthea Ltd : Leerink Partners Cuts to Market Perform From Outperform; Cuts Target Price to $1 From $12

THOMSON REUTERS
·
25 Mar

Health Check: Bargain hunters flock to 4D Medical’s discounted raising

Stockheads
·
25 Mar